ESMO Preceptorship on Colorectal Cancer Barcelona November 2016

Oncology Meeting Resources

25 Nov - 26 Nov, Barcelona, Spain

ESMO Preceptorship on Colorectal Cancer square

Main learning objectives for the ESMO Preceptorship on Colorectal Cancer Barcelona November 2016 included learning about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; understanding the importance of pathology and histoprognostic factors and learning bout the management of patients after progression, side-effect treatments and in special situation.

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
C.-H. Köhne, DE Adjuvant Treatment for Colon Cancer III Session 2 - Adjuvant Settings of Colorectal Cancer
F. Bibeau, FR Microsatellite Instability and Other Molecular Markers - How Useful Are They? Session 2 - Adjuvant Settings of Colorectal Cancer
J.-Y. Douillard, FR ESMO Preceptorship on Colorectal Cancer Welcome and Introduction
P. Piso, DE Salvage Surgery of Anal Canal Squamous Carcinomas Session 7 - Anal Canal Tumours
R. Glynne-Jones, UK Standard of Care for Anal Canal Squamous Carcinomas Session 7 - Anal Canal Tumours
N. Fotker Dovnik, SI Participant Clinical Case Discussion: Treatment-related Diarrhea in a Patient with Metastatic Colon Cancer Session 6 - Metastatic Colorectal Cancer II
F. Bratu, RO Participant Clinical Case Discussion: Colon Carcinoma Stage IV Session 6 - Metastatic Colorectal Cancer II
O. Ayodele, IE Participant Clinical Case Discussion: Against All Odds Session 6 - Metastatic Colorectal Cancer II
M. Ducreux, FR Management of Treatment Related Side Effects Session 6 - Metastatic Colorectal Cancer II
A. Cervantes, ES What to Do After 1st-Line Failure Session 5 - Metastatic Colorectal Cancer II
R. Salazar,ES Chemotherapy and Targeted Agents in 1st Line Session 4 - Special Clinical Situations: Mono- or Oligometastatic Disease
M. Ducreux, FR The Role of Maintenance, Appropriate Endpoints According to ESMO Consensus Session 5 - Metastatic Colorectal Cancer I
P. Piso, DE Treatment of Metastatic Disease Confined to the Peritoneum Session 4 - Special Clinical Situations: Mono- or Oligometastatic Disease
C. Matthaiou, CY Participant Clinical Case Discussion: Stage IV Rectal Cancer with CR Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases
S. Puia-Negulescu, BE Participant Clinical Case Discussion: Multidisciplinary Management of a Case of Perforated Colon Cancer Associated with Unresectable Hepatic Metastasis Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases